https://teledirectmd.com/health-guides/xocova-ensitrelvir-covid-pep-2026/
FDA Approves Xocova (Ensitrelvir) for COVID-19 Post-Exposure Prophylaxis: What the Evidence Shows |...
Jun 8, 2026 - The FDA approved Xocova (ensitrelvir) on May 29, 2026 for COVID-19 post-exposure prophylaxis. A clinical review of the SCORPIO-PEP trial, mechanism, dosing,...
post exposure prophylaxiswhat thefdaapprovesxocova